CHINA PHARMA HOLDINGS, INC. (CPHI)

↓ Download CSV

CIK 0001106644 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, CHINA PHARMA HOLDINGS, INC. reported revenue of $4.14M, down 8.5% from the prior year. The company ran a net loss, with a net margin of -76.9% and a gross margin of -3.2%. It held $31.00M in total assets against $8.26M in total liabilities.

Key ratios (FY2025)

-3.2%
Gross margin
-78.2%
Operating margin
-76.9%
Net margin
-14.0%
Return on equity
-8.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$4.14M$4.53M$7.01M$8.10M$9.64M$10.87M$10.92M$12.33M$13.21M$15.57M
Cost of Revenue$4.28M$6.51M$7.29M$8.60M$9.29M$8.91M$9.44M$10.36M$10.74M$12.35M
Gross Profit-$131.9K-$1.99M-$281.1K-$493.9K$349.3K$1.95M$1.48M$1.97M$2.47M$3.22M
Operating Income-$3.24M-$4.59M-$2.75M-$3.55M-$2.86M-$2.58M-$20.41M-$10.45M-$18.68M-$8.16M
Net Income-$3.19M-$4.74M-$3.08M-$3.97M-$3.40M-$2.87M-$20.70M-$10.75M-$19.28M-$9.18M
EPS (Diluted)$-0.74$-2.71$-0.91$-3.78$-0.74
Total Assets$31.00M$14.89M$16.47M$17.78M$22.65M$21.12M$22.24M$45.38M$59.95M$78.52M
Total Liabilities$8.26M$7.14M$9.01M$13.49M$16.63M$13.11M$13.00M$15.18M$16.88M$19.61M
Shareholders' Equity$22.74M$7.75M$7.45M$4.29M$6.02M$8.00M$9.24M$30.20M$43.07M$58.91M
Cash & Equivalents$345.1K$626.9K$1.42M$2.03M$4.86M$957.7K$1.07M$1.19M$2.03M$2.67M
Operating Cash Flow$148.3K-$406.1K-$699.7K-$409.5K-$249.8K-$42.3K$608.3K$1.88M$841.2K$2.90M
Capital Expenditures$59.3K$38.4K$11.5K$402.0K$438.1K$867.3K$136.0K$51.1K$136.5K$193.4K
Shares Outstanding15.52M3.26M10.63M1.50M4.73M45.58M43.58M43.58M43.58M43.58M